4,689
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors

, , , , , , , , , & show all
Article: 2182058 | Received 13 Oct 2022, Accepted 06 Feb 2023, Published online: 24 Feb 2023